Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial (NCT03150914)

🧪 Interventions in This Study

• Sirolimus (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (8 Sites)

• Stanford University — Palo Alto, California
• National Jewish Hospital — Denver, Colorado
• Emory University — Atlanta, Georgia
• Loyola University — Chicago, Illinois
• Brigham and Woman's Hospital — Boston, Massachusetts
• University of Cincinnati — Cincinnati, Ohio
• University of Pennsylvania — Philadelphia, Pennsylvania
• Swedish Health — Seattle, Washington

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All LAM clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.